Total Payments
$176,635
2024 Payments
$5,919
Companies
23
Transactions
215
Medicare Patients
3,688
Medicare Billing
$474,877
Payment Breakdown by Category
Other$122,293 (69.2%)
Consulting$41,626 (23.6%)
Travel$7,502 (4.2%)
Food & Beverage$4,990 (2.8%)
Research$168.75 (0.1%)
Education$54.84 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $93,052 | 46 | 52.7% |
| Consulting Fee | $41,626 | 20 | 23.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,241 | 17 | 16.6% |
| Travel and Lodging | $7,502 | 20 | 4.2% |
| Food and Beverage | $4,990 | 106 | 2.8% |
| Unspecified | $168.75 | 1 | 0.1% |
| Education | $54.84 | 5 | 0.0% |
Payments by Type
General
$176,467
214 transactions
Research
$168.75
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $165,780 | 162 | $0 (2023) |
| Genentech USA, Inc. | $4,659 | 2 | $0 (2024) |
| Horizon Pharma plc | $3,868 | 4 | $0 (2018) |
| Janssen Global Services, LLC | $605.00 | 1 | $0 (2024) |
| Amgen Inc. | $327.31 | 4 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $208.19 | 8 | $0 (2024) |
| Merz North America, Inc. | $162.49 | 3 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $152.11 | 3 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $119.29 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $114.55 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,919 | 17 | Genentech USA, Inc. ($4,659) |
| 2023 | $35,154 | 41 | Horizon Therapeutics plc ($35,006) |
| 2022 | $19,680 | 33 | Horizon Therapeutics plc ($19,680) |
| 2021 | $54,090 | 60 | Horizon Therapeutics plc ($54,004) |
| 2020 | $56,908 | 38 | Horizon Therapeutics plc ($56,857) |
| 2019 | $635.04 | 11 | Horizon Therapeutics plc ($233.56) |
| 2018 | $3,969 | 5 | Horizon Pharma plc ($3,868) |
| 2017 | $280.66 | 10 | Carl Zeiss Meditec, Inc. ($119.29) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/08/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/06/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $605.00 | General |
| 08/07/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.08 | General |
| 06/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Dry eyes | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Consulting Fee | Cash or cash equivalent | $4,390.00 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $268.52 | General |
| Category: Immunology | ||||||
| 03/16/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $51.93 | General |
| Category: Ophthalmology | ||||||
| 03/06/2024 | Amgen Inc. | TEPEZZA (Biological) | — | In-kind items and services | $168.75 | Research |
| Study: Inactive Thyroid Eye Disease Patient Journey • Category: Inflammation/Rare Disease | ||||||
| 03/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Rare Disease | ||||||
| 01/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $650.00 | General |
| Category: TEPEZZA | ||||||
| 11/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Rare Disease | ||||||
| 11/03/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: TEPEZZA | ||||||
| 10/31/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Rare Disease | ||||||
| 10/12/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Rare Disease | ||||||
| 08/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $136.44 | General |
| Category: TEPEZZA | ||||||
| 08/22/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: TEPEZZA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Inactive Thyroid Eye Disease Patient Journey | Amgen Inc. | $168.75 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 846 | 1,138 | $291,143 | $97,834 |
| 2022 | 17 | 1,109 | 4,916 | $497,725 | $135,249 |
| 2021 | 17 | 908 | 3,552 | $416,030 | $129,984 |
| 2020 | 20 | 825 | 3,445 | $327,065 | $111,809 |
Total Patients
3,688
Total Services
13,051
Medicare Billing
$474,877
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 28 | 28 | $66,672 | $19,057 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 182 | $45,567 | $17,580 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 185 | $28,297 | $12,462 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $26,503 | $10,287 | 38.8% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2023 | 15 | 16 | $25,791 | $7,300 | 28.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 87 | 136 | $17,787 | $6,802 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $12,402 | $5,710 | 46.0% |
| 67950 | Reconstruction of eyelid margin | Facility | 2023 | 14 | 16 | $25,948 | $4,598 | 17.7% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 61 | 88 | $11,700 | $4,301 | 36.8% |
| 92134 | Imaging of retina | Office | 2023 | 75 | 118 | $10,131 | $3,492 | 34.5% |
| 92285 | Photography of content of eyes | Office | 2023 | 148 | 177 | $10,371 | $3,051 | 29.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 26 | 32 | $3,920 | $2,539 | 64.8% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2023 | 12 | 13 | $6,054 | $655.70 | 10.8% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 42 | 43 | $131,639 | $27,372 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 310 | $50,355 | $21,960 | 43.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 23 | 3,563 | $27,629 | $17,125 | 62.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $44,662 | $12,968 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 76 | $16,697 | $8,075 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $17,342 | $7,143 | 41.2% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2022 | 17 | 17 | $35,391 | $6,814 | 19.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 107 | 123 | $15,176 | $6,209 | 40.9% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 22 | 46 | $26,132 | $5,981 | 22.9% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 77 | 106 | $20,072 | $5,577 | 27.8% |
| 67950 | Reconstruction of eyelid margin | Facility | 2022 | 12 | 14 | $37,499 | $4,751 | 12.7% |
| 92285 | Photography of content of eyes | Office | 2022 | 167 | 198 | $22,332 | $3,490 | 15.6% |
About Dr. Kimberly Cockerham, MD
Dr. Kimberly Cockerham, MD is a Ophthalmology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366493629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimberly Cockerham, MD has received a total of $176,635 in payments from pharmaceutical and medical device companies, with $5,919 received in 2024. These payments were reported across 215 transactions from 23 companies. The most common payment nature is "Honoraria" ($93,052).
As a Medicare-enrolled provider, Cockerham has provided services to 3,688 Medicare beneficiaries, totaling 13,051 services with total Medicare billing of $474,877. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Neuro-ophthalmology
- Location San Diego, CA
- Active Since 05/12/2006
- Last Updated 11/06/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1366493629
Products in Payments
- TEPEZZA (Drug) $162,200
- Enspryng (Biological) $4,659
- TEPRO (Drug) $3,868
- UPLIZNA (Drug) $2,087
- TEPEZZA (Biological) $327.31
- ACTHAR (Biological) $251.10
- PLEX Elite 9000 (Device) $119.29
- GILENYA (Drug) $100.67
- ULTOMIRIS (Biological) $80.01
- XIIDRA (Drug) $75.39
- Soliris (Drug) $54.29
- Clareon (Device) $51.93
- PURIFIED CORTROPHIN GEL (Drug) $49.57
- SOLIRIS (Drug) $42.41
- XDEMVY (Drug) $39.57
- TYRVAYA (Drug) $38.25
- SOLIRIS (Biological) $31.48
- Oxervate (Drug) $29.38
- OXERVATE (Drug) $24.57
- XEOMIN (Biological) $22.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Diego
Nikolas London, M.d, M.D
Ophthalmology — Payments: $545,087
Ophthalmology $545,087
Dr. Robert Weinreb, Md, MD
Ophthalmology — Payments: $515,649
Ophthalmology $515,649
Dr. Eric Nudleman, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $335,929
Ophthalmology $335,929
Dr. Michael Gordon, M.d, M.D
Ophthalmology — Payments: $190,040
Ophthalmology $190,040
Dr. Manoj Motwani, M.d, M.D
Ophthalmology — Payments: $165,397
Ophthalmology $165,397
Atul Jain, M.d, M.D
Ophthalmology — Payments: $113,102
Ophthalmology $113,102